MARCANTHONY MORGAN: Open Payments
NPI 1427475722 · BONITA SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 22 payments from 13 companies in 2025. Trend: 2023 $382 · 2024 $235 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $36 |
| Lundbeck LLC | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: REXULTI, CAPLYTA, AIRSUPRA, TZIELD, Dexcom G6 Transmitter, YUPELRI, PROQUAD, VRAYLAR.
Industry payments across FL — which companies pay providers there.
